-
-
-
-
-
-
-
Alpha Cognition appoints Bethany Sensenig to board of directors
-
-
-
-
-
-
-
Leerink Partners on Kalvista Pharmaceuticals Inc (KALV): 'we continue to view this as a launch investors should own'
-
-
-
-
-
-
-
KalVista reports $49 million revenue for EKTERLY in 2025
-
-
-
-
-
-
-
Kalvista Pharma's (KALV) Ekterly Launch Looks Strong - Citizens
-
-
-
-
-
-
-
Kalvista Pharmaceuticals Inc (KALV) PT Raised to $28 at Citizens JMP
-
-
-
-
-
-
-
KalVista wins UK approval for oral hereditary angioedema treatment
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)
-
408,193 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

